Investment Fraud: Hector Absi Pleads Guilty To Conspiracy To Commit Mail, Wire, And Securities Fraud

<h2>Former Chief Operating Officer of Davis Bio-Pesticide Company Pleads Guilty to Conspiracy to Commit Mail&comma; Wire&comma; and Securities Fraud<&sol;h2>&NewLine;<p>SACRAMENTO&comma; Calif&period; — Hector Absi&comma; 51&comma; of Las Vegas&comma; Nevada&comma; pleaded guilty today to one count of conspiracy to commit mail fraud&comma; wire fraud&comma; and securities fraud&comma; U&period;S&period; Attorney McGregor W&period; Scott announced&period;<&sol;p>&NewLine;<p>According to court documents&comma; Absi is the former head of the sales department of Marrone Bio Innovations Inc&period; &lpar;MBI&rpar;&comma; a company headquartered in Davis&comma; California that produces &OpenCurlyDoubleQuote;bio-based” pesticides&period; Absi also served as MBI’s Chief Operating Officer from January 2014 until his resignation in August 2014&period; MBI is a publicly traded company&semi; its stock trades on the NASDAQ exchange under the ticker symbol &OpenCurlyDoubleQuote;MBII&period;” As a publicly traded company&comma; it is required to file quarterly and annual reports with the Securities and Exchange Commission &lpar;SEC&rpar;&period; In its reports&comma; MBI stated that it recorded revenue in accordance with generally accepted accounting principles &lpar;GAAP&rpar;&period;<&sol;p>&NewLine;<p>According to Absi’s plea agreement&comma; in order to increase sales&comma; Absi sold MBI products to customers with side agreements that offered &OpenCurlyDoubleQuote;inventory protection” under which MBI agreed to either repurchase the product from the customer or continue the date by which the customer would need to make full payment for the product&period; Under GAAP&comma; revenue from sales that include such agreements cannot be recognized on the company’s books at the time of the sales&period; Between March 2013 and July 2014&comma; Absi conspired with at least one other MBI employee to misrepresent to MBI’s accounting department&comma; its external auditors&comma; and the investing public that MBI had made sales under such terms&period; By concealing the practice&comma; Absi caused MBI to report a doubling of its revenue in 2013 in comparison to 2012&period; Absi also conspired to backdate the delivery of certain shipments of MBI’s products to enhance MBI’s reported revenues for the quarter&period; Absi received a performance-based bonus and exercised stock options during a time when MBI’s inflated revenue figures were being reported&period;<&sol;p>&NewLine;<p>The Securities and Exchange Commission has also filed a civil complaint against Absi in the U&period;S&period; District Court for the Eastern District of California&comma; alleging that Absi violated the Securities Act of 1933&comma; and the Securities Exchange Act of 1934&comma; and federal rules issued under the Exchange Act&comma; and seeking an injunction against Absi&comma; disgorgement of wrongfully obtained benefits&comma; and civil penalties&period;<&sol;p>&NewLine;<p>This case is the product of an investigation by the Federal Bureau of Investigation&period; Assistant U&period;S&period; Attorney Lee S&period; Bickley is prosecuting the case&period;<&sol;p>&NewLine;<p>U&period;S&period; District Judge Morrison C&period; England Jr&period; is scheduled to sentence Absi on Feb&period; 20&comma; 2020&period; Absi faces a maximum statutory penalty of 25 years in prison and a &dollar;250&comma;000 fine or twice the gross loss or gain&period; The actual sentence&comma; however&comma; will be determined at the discretion of the court after consideration of any applicable statutory factors and the Federal Sentencing Guidelines&comma; which take into account a number of variables&period;<&sol;p>&NewLine;